Description

(6-Bromo-4-((4-Methyl-3-Nitrophenyl)Amino)Quinolin-3-Yl)Methanol is a high-purity, advanced pharmaceutical intermediate characterized by its complex quinoline-based molecular structure. This compound matters for its critical role as a key building block in the synthesis of novel, targeted small-molecule therapeutics, particularly in oncology and antiviral research. Pharmaceutical R&D laboratories and fine chemical manufacturers need this precise intermediate to develop and scale up new drug candidates, ensuring process consistency and regulatory compliance.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the multi-step synthesis of investigational new drugs (INDs) and active pharmaceutical ingredients (APIs).
• Oncology Research: Used in the development of kinase inhibitors and other targeted cancer therapies due to its quinoline scaffold.
• Antiviral Drug Development: Employed as a building block for creating compounds with potential activity against viral pathogens.
• Chemical Biology & Proteomics: Utilized in the design and synthesis of molecular probes for studying enzyme function and protein interactions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Used in university and institutional labs for medicinal chemistry projects and novel heterocyclic compound exploration.

Basic Information

Product Name	(6-Bromo-4-((4-Methyl-3-Nitrophenyl)Amino)Quinolin-3-Yl)Methanol
CAS No.	1431510-25-6
Molecular Formula	C17H14BrN3O3
Molecular Weight	388.22 g/mol
Synonyms	3-Quinolinemethanol, 6-bromo-4-[(4-methyl-3-nitrophenyl)amino]-; 4-((4-Methyl-3-nitrophenyl)amino)-6-bromoquinolin-3-ylmethanol; 6-Bromo-4-((4-methyl-3-nitrophenyl)amino)-3-quinolinemethanol; (6-Bromo-4-((4-methyl-3-nitrophenyl)amino)quinolin-3-yl)methanol; CAS 1431510-25-6
EINECS	Contact for details

Quality Control

Every batch of (6-Bromo-4-((4-Methyl-3-Nitrophenyl)Amino)Quinolin-3-Yl)Methanol is produced and tested under a strict quality management system. We provide comprehensive analytical data to ensure the material meets the high-purity standards required for pharmaceutical R&D and scale-up. A detailed Certificate of Analysis (COA) is supplied with each shipment, documenting identity, purity (typically >97% by HPLC), and impurity profiles. Our quality protocols are designed to support regulatory filings.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	Yellow to brown solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Any single impurity ≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.